Lv4
628 积分 2021-11-16 加入
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
1个月前
已完结
Redefining the Cerebral Ischemic Core-Penumbra-Oligemia Continuum
3个月前
已完结
Contribution of Tumor Treating Fields (TTFields) to Survival Outcomes in Newly Diagnosed Glioblastoma: A Multicenter Retrospective Study
5个月前
已完结
Meningeal blood vessel blockage enhances anti-glioblastoma immunity
6个月前
已完结
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessment
8个月前
已完结
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 1: intraoperative recommendations for mapping, monitoring, and decision making
8个月前
已完结
Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial
9个月前
已完结
Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis
9个月前
已完结
Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial
9个月前
已完结
皖公网安备34019202002308
